Article Information
History
- September 17, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- G. Padalino1,
- C. A. Celatka2,
- H. Y. Rienhoff Jr.2,
- J. H. Kalin3,
- P. A. Cole3,
- D. Lassalle4,
- C. Grunau4,
- I. W. Chalmers1,
- A. Brancale5 and
- K. F. Hoffmann1,*
- 1Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University, Aberystwyth, SY23 3DA, United Kingdom
- 2Imago BioSciences, 2729 Debbie Court, San Carlos, CA 94070, United States
- 3Division of Genetics, Department of Medicine, Brigham and Women’s Hospital and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, United States
- 4IHPE, Univ. Montpellier, CNRS, Ifremer, University Perpignan, Via Domitia, 58 Av Paul Alduy, 66860 Perpigna, France
- 5School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff, CF10 3NB, United Kingdom
- ↵*To whom correspondence should be addressed, Telephone – 011 44 (0) 1970 622 237, Telefax – 011 44 (0) 1970 621 981, Email address – krh{at}aber.ac.uk
Posted September 17, 2020.
Schistosoma mansoni lysine specific demethylase 1 (SmLSD1) is a druggable target involved in parasite survival, oviposition and stem cell proliferation
